Scientific Advisory Board

Dr. Roy Duncan, Dalhousie University
Halifax, NS

Dr. Duncan is Associate Professor in the Department of Microbiology and Immunology at Dalhousie University. His educational background includes a B.Sc. in microbiology (University of Guelph) and M.Sc. (Queen's University) and Ph.D. (University of Guelph) degrees in molecular virology. Following his postdoctoral research in virology with Dr. Patrick Lee at the University of Calgary, he has continued to investigate viruses, working on structure-function relationships in the mammalian reovirus cell attachment protein. Since discovering the fusion-associated small transmembrane (FAST) proteins in the 1990s, Dr. Duncan went on to develop these proteins into powerful new strategies against cancer. He founded Fusogenix Inc. in 2003 and today is an integral technical consultant as Innovascreen takes the Fusogenix platform through further preclinical testing and onto clinical testing.

Dr. Missag Parseghian
Stonsa Biopharm, Carlsbad, CA

Dr. Parseghian is currently Director of R&D at Stonsa Biopharm. He received his Doctorate in Molecular Biology and Biochemistry from the Univ. of California, Irvine; and conducted post-graduate work in collaboration with Los Alamos Natl. Laboratory. He actively publishes and lectures in the area of chromatin structure, gene regulation, nuclear proteins and their relationship to cancer therapy.

Dr. Carman Giacomantonio
QEII Health Sciences Centre, Halifax, NS

Dr. Giacomantonio graduated from the Faculty of Medicine of Memorial University in 1991 and did general surgical training at Dalhousie 1992-1997. He completed an M.Sc. in Pathology in 1998 and from 1997 to 1999 was training at the University of Calgary in Surgical Oncology. He returned to Dalhousie in 1999 where he is currently Assistant Professor of Surgery and a General Surgeon and Surgical Oncologist at the Queen Elizabeth II Health Sciences Center. He is Head of the Surgical Oncology Network for Cancer Care Nova Scotia. Dr. Giacomantonio has won the Canadian Association of General Surgeons Resident Award for Teaching Excellence, Excellence in Teaching Award of the Department of Surgery and the Stevens Norvell Jr. Teaching Excellence Award. His major areas of research are in Melanoma and Breast Cancer. He is known for his work on sentinel node surgery in both breast cancer and melanoma. His laboratory based research relates to breast cancer cells and melanoma mouse cells. He currently holds research grant awards from the Canadian Breast Cancer Foundation.